Prednisone
Hypogonadism
SWOG Cancer Research NetworkSmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 95/ 100
Competitive context
16 Active assets in the Hypogonadism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Testosterone Undecylate Royal College of Surgeons, Ireland | Phase 3 | BB |
Carboplatin University of Washington | Phase 2 | BB |
Abiraterone SWOG Cancer Research Network | Phase 3 | BB |
Docetaxel SWOG Cancer Research Network | Phase 3 | BB |
Semaglutide University Medical Centre Ljubljana | Phase 3 | BB |
View all 35 →
Same molecule, other indications
Prednisone is also rated in:
peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →